BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9488475)

  • 1. The Rho family G proteins play a critical role in muscle differentiation.
    Takano H; Komuro I; Oka T; Shiojima I; Hiroi Y; Mizuno T; Yazaki Y
    Mol Cell Biol; 1998 Mar; 18(3):1580-9. PubMed ID: 9488475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mouse MRF4 promoter is trans-activated directly and indirectly by muscle-specific transcription factors.
    Black BL; Martin JF; Olson EN
    J Biol Chem; 1995 Feb; 270(7):2889-92. PubMed ID: 7852366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG.
    Zalcman G; Closson V; Camonis J; Honoré N; Rousseau-Merck MF; Tavitian A; Olofsson B
    J Biol Chem; 1996 Nov; 271(48):30366-74. PubMed ID: 8939998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling.
    Olofsson B
    Cell Signal; 1999 Aug; 11(8):545-54. PubMed ID: 10433515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
    Dhawan J; Helfman DM
    J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis.
    Naidu PS; Ludolph DC; To RQ; Hinterberger TJ; Konieczny SF
    Mol Cell Biol; 1995 May; 15(5):2707-18. PubMed ID: 7739551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and rac I.
    Adra CN; Ko J; Leonard D; Wirth LJ; Cerione RA; Lim B
    Genes Chromosomes Cancer; 1993 Dec; 8(4):253-61. PubMed ID: 7512369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
    Sun J; Barbieri JT
    J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho GTPases are over-expressed in human tumors.
    Fritz G; Just I; Kaina B
    Int J Cancer; 1999 May; 81(5):682-7. PubMed ID: 10328216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for RhoGDI as an inhibitor of GAP proteins.
    Hancock JF; Hall A
    EMBO J; 1993 May; 12(5):1915-21. PubMed ID: 8491184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Rho and Rac small G proteins and Rho GDI in Ca2+-dependent exocytosis from PC12 cells.
    Komuro R; Sasaki T; Takaishi K; Orita S; Takai Y
    Genes Cells; 1996 Oct; 1(10):943-51. PubMed ID: 9077452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.
    Ahmad Mokhtar AMB; Ahmed SBM; Darling NJ; Harris M; Mott HR; Owen D
    Biochemistry; 2021 May; 60(19):1533-1551. PubMed ID: 33913706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
    Ridgeway AG; Wilton S; Skerjanc IS
    J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.
    Muscat GE; Rea S; Downes M
    Nucleic Acids Res; 1995 Apr; 23(8):1311-8. PubMed ID: 7753622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of RhoGDI and RhoA regulation by a Rac1 specificity switch mutant.
    Wong KW; Mohammadi S; Isberg RR
    J Biol Chem; 2006 Dec; 281(52):40379-88. PubMed ID: 17074770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex.
    de la Serna IL; Ohkawa Y; Berkes CA; Bergstrom DA; Dacwag CS; Tapscott SJ; Imbalzano AN
    Mol Cell Biol; 2005 May; 25(10):3997-4009. PubMed ID: 15870273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts.
    Carnac G; Primig M; Kitzmann M; Chafey P; Tuil D; Lamb N; Fernandez A
    Mol Biol Cell; 1998 Jul; 9(7):1891-902. PubMed ID: 9658178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monomeric G-proteins Rac1 and/or Cdc42 are required for the inhibition of voltage-dependent calcium current by bradykinin.
    Wilk-Blaszczak MA; Singer WD; Quill T; Miller B; Frost JA; Sternweis PC; Belardetti F
    J Neurosci; 1997 Jun; 17(11):4094-100. PubMed ID: 9151726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How RhoGDI binds Rho.
    Longenecker K; Read P; Derewenda U; Dauter Z; Liu X; Garrard S; Walker L; Somlyo AV; Nakamoto RK; Somlyo AP; Derewenda ZS
    Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1503-15. PubMed ID: 10489445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.